Money Concepts Capital Corp Medpace Holdings, Inc. Transaction History

Money Concepts Capital Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$372.0 - $424.34 $6,696 - $7,638	-18 Reduced 3.57%	486 $200,000
Q1 2024 May 01, 2024	BUY	$284.87 - $413.31 $143,574 - $208,308	504 New	504 $203,000
Q3 2023 Oct 31, 2023	SELL	$233.98 - $281.67 $24,333 - $29,293	-104 Reduced 10.96%	845 $204,000
Q2 2023 Jul 31, 2023	SELL	$187.26 - $240.17 $197,559 - $253,379	-1,055 Reduced 52.64%	949 $227,000
Q1 2023 May 01, 2023	BUY	$174.31 - $239.52 $160,190 - $220,118	919 Added 84.7%	2,004 $376,000
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $3,673 - $5,437	-24 Reduced 2.16%	1,085 $230,000
Q3 2022 Oct 27, 2022	SELL	$145.13 - $182.49 $5,514 - $6,934	-38 Reduced 3.31%	1,109 $174,000
Q2 2022 Jul 18, 2022	SELL	$130.2 - $168.03 $3,254 - $4,200	-25 Reduced 2.13%	1,147 $172,000
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $12,081 - $18,644	-87 Reduced 6.91%	1,172 $192,000
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $4,385 - $5,469	24 Added 1.94%	1,259 $274,000
Q1 2021 May 17, 2021	BUY	$132.02 - $168.26 $163,044 - $207,801	1,235 New	1,235 $203,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.